BP lowering, metformin, lipoprotein A, and GLP1+

TT HealthWatch - Nov. 20, 2026
Elizabeth Tracey and Dr. Richard Lange

This week's topics include intensive bp lowering in people with diabetes, metformin for long Covid, lowering lipoprotein A, and GLP1+ for knee OA in people who are overweight.

Program notes:

0:50 Lowering lipoprotein a and CVD

1:50 Pelacarsen administered subcutaneously

2:50 More risk factors you reduce the better

3:15 Retatrutide for knee OA and obesity

4:15 Did reduce knee pain as well as reduced weight

5:15 Almost 38% reduction in placebo group

6:00 Intensive blood pressure lowering in T2D

7:00 Doesn't reduce major cardiovascular events

7:45 Metformin and long Covid

8:45 Primary outcome long Covid or death

9:50 Looked like a benefit with metformin

10:52 "immortal time bias"

11:48 End

Next
Next

Colorectal cancer, AI authorization, T cells, ALS, and T1D